Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction 
 
Healthcare contract research organization (CRO) provides support and services as biologic assay development, clinical research, commercialization, preclinical research, clinical trials management and biopharmaceutical development to biotechnology, pharmaceutical and medical device industries. Healthcare contract research organization helps in improvement of people by offering professional and high quality service solutions. The report provides analysis of global healthcare contract research organization (CRO) market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. The global healthcare contract research organization (CRO) market is anticipated to grow at considerable CAGR above 6.5% over the forecast period and reach US$ 54.82 Bn by 2026. 
 
Market Dynamics
 
With expanding number of organizations to recognize biologics and new mixes, and growing R&D costs, medicate creators and support organizations are feeling the squeeze to supplant income misfortune explicitly because of generics. This has further made drug development more complex expensive and hence augmenting the market growth. In various countries due to complex regulatory framework for drug discovery and development, the need for expertise for drug development is increasing, thereby boosting the demand for outsourcing services. With growing privatization of clinical trials, the outsourcing of manufacturing processes is increasing in developing countries. 
 
Moreover, increasing pressure on industry players to follow rigorous regulations as well as timelines is supplementing the demand for outsourcing of research activities. Government organizations are also outsourcing their clinical trials to various contract research organizations for required infrastructure and expertise. Healthcare CROs’ are enhancing their portfolio by integrating services with advanced technology in order to deliver desired and efficient results to clients. However, lack of skilled research professionals may hinder the growth of the overall market.
 
Market Segmentation

Market by Product

  • Drug Discovery
    • Target validation
    • Lead identification
    • Lead optimization
  • Pre-Clinical
  • Clinical
  • Phase I Trial Services
  • Phase II Trial Services
  • Phase III Trial Services
  • Phase IV Trial Services

Market by Service

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and site Recruitment
  • Technology
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA
The market research study on “Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026” offers a detailed insights on global healthcare contract research organization (CRO)market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global healthcare contract research organization (CRO)market by type, service and major geographic regions. The report also covers basic healthcare development policies. Secondly, the report covers global healthcare contract research organization (CRO) market size and segment markets by type, service and geography along with the information on companies operating in the market. 

Report Coverage

Market

Healthcare Contract Research Organization (CRO) Market

Analysis Period

2016– 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Intervention, Distribution method and Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 
Market Participants
 
The company profiling of key players in the global healthcare contract research organization (CRO) market includes company overview, major business strategies and revenues. The key players of the market are Laboratory Corporation of America Holdings, PRA Health Sciences, Charles River Laboratories, Inc., Pharmaceutical Product Development, LLC, Quintiles IMS Holdings, Inc., PAREXEL International Corporation, inVentiv Health, Inc. and ICON plc.


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary